SG11202009013QA - Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract - Google Patents

Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract

Info

Publication number
SG11202009013QA
SG11202009013QA SG11202009013QA SG11202009013QA SG11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA SG 11202009013Q A SG11202009013Q A SG 11202009013QA
Authority
SG
Singapore
Prior art keywords
delivering
respiratory tract
bioactive substances
substances targeting
amphiphilic
Prior art date
Application number
SG11202009013QA
Other languages
English (en)
Inventor
Erik Chun Hay Ko
Connie Sau Kuen Kwok
Original Assignee
Wise Ally Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wise Ally Holdings Ltd filed Critical Wise Ally Holdings Ltd
Publication of SG11202009013QA publication Critical patent/SG11202009013QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/78—Saururaceae (Lizard's-tail family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
    • A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202009013QA 2018-03-26 2019-03-25 Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract SG11202009013QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862647843P 2018-03-26 2018-03-26
PCT/CN2019/079445 WO2019184840A1 (en) 2018-03-26 2019-03-25 Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract

Publications (1)

Publication Number Publication Date
SG11202009013QA true SG11202009013QA (en) 2020-10-29

Family

ID=68059444

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009013QA SG11202009013QA (en) 2018-03-26 2019-03-25 Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract

Country Status (6)

Country Link
US (1) US20210128461A1 (zh)
CN (1) CN111867602A (zh)
AU (1) AU2019241169A1 (zh)
SG (1) SG11202009013QA (zh)
TW (1) TW201946634A (zh)
WO (1) WO2019184840A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1030599B1 (fr) * 2022-11-23 2024-01-09 Erck Emmanuelle Van Composition à base d'huiles essentielles pour le traitement et la prévention des maladies inflammatoires des voies aériennes chez les animaux

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4106026A1 (de) * 1991-02-26 1992-08-27 Plantamed Arzneimittel Gmbh Pharmazeutische zubereitungen enthaltend eine gallussaeureverbindung und/oder quercetin sowie verfahren zur isolierung dieser verbindungen
CN101036771A (zh) * 2006-03-15 2007-09-19 北京琥珀光华医药科技开发有限公司 一种用于治疗肺炎和上呼吸道感染的中药喷雾剂
CN100563670C (zh) * 2007-02-08 2009-12-02 中国药品生物制品检定所 一种治疗咳嗽哮喘的中药组合物
CN101234168B (zh) * 2008-03-11 2010-09-29 浙江大学 一种复方当归制剂及制备方法和用途
CH703437A2 (fr) * 2010-07-01 2012-01-13 Guenter Holzner Mélange d'huiles essentielles comme thérapie accompagnante pour le traitement de la tuberculose pulmonaire.
CN204684370U (zh) * 2015-04-21 2015-10-07 惠州市锦好电子有限公司 一种基于模块控制的药物雾化吸入器
CN106729011A (zh) * 2016-11-28 2017-05-31 医源堂（北京）科技有限公司 一种外用组合物

Also Published As

Publication number Publication date
WO2019184840A1 (en) 2019-10-03
US20210128461A1 (en) 2021-05-06
AU2019241169A1 (en) 2020-10-08
TW201946634A (zh) 2019-12-16
CN111867602A (zh) 2020-10-30

Similar Documents

Publication Publication Date Title
IL251462A0 (en) Pharmaceutical formulations for oral administration of peptide or protein drugs
IL258464A (en) Pharmaceutical compositions for oral administration of peptide drugs
IL258713A (en) Spray delivery system and method for operating a spray delivery system
HK1251978A1 (zh) 非燃燒型香味吸入器及霧化組件
HK1246103A1 (zh) 非燃燒型香味抽吸器、香吸味源單元及霧化單元
IL283840A (en) Preparations for administering therapeutic substances and methods for their use and preparation
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
HK1246101A1 (zh) 非燃燒式香味吸引器及氣溶膠輸送方法
EP3697481A4 (en) NASAL DRUG DELIVERY DEVICE AND METHOD OF USE
EP3752231A4 (en) METHOD AND INHALER FOR DELIVERING AT LEAST TWO SUBSTANCES BY INHALATION
EP3806939A4 (en) DEVICE FOR USE IN RESPIRATORY MEDICATION ADMINISTRATION
GB201516802D0 (en) Apparatus and method for determination of the dose of a powder inhalation formulation
EP3520633A4 (en) FLAVOR INHALER AND ATOMIZATION UNIT
HK1247140A1 (zh) 用於藥物有效地呼吸同步遞送到肺部的方法和系統
IL272684A (en) Exosomes for specific delivery of a target and methods for its preparation and delivery
PT3307293T (pt) Formulações para o tratamento de distúrbios da boca, garganta e trato respiratório
IL282538A (en) Methods for manufacturing therapeutic delivery platforms
HK1257588A1 (zh) 預防和治療肺纖維化的藥物及其用途
ZA201800470B (en) An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
SG11202009013QA (en) Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract
IL275690A (en) Nanoparticles for targeted delivery of therapeutic polypeptides
FI3986515T3 (fi) Hengitystien annostelulaite ja -menetelmä
GB201621559D0 (en) A method for the preparation of a delivery drug delivery system and a composition therefor
IL271596A (en) Preparations for administering drugs and methods of using them
ZA201605133B (en) Pressurised metered dose inhalers and method of manufacture